Aldehyde Scavenging Agents for Antigen Retrieval

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for protein detection in tissues fixed with aldehyde-based cross-linking agents face challenges in unmasking antigens and reversing aldehyde modifications, leading to impaired antigen retrieval and reduced reproducibility in immunohistochemical analyses.

Innovation Solution

A method involving aldehyde scavenging agents, which are used to prepare a solution that reacts with aldehydes in fixed tissues, shifting the equilibrium to release masked proteins, thereby unmasking them and improving detection, along with optional nonionic surfactants to enhance fluorescence and reduce autofluorescence.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If aldehyde-based cross-linking agents are used for tissue fixation, then tissue preservation is improved, but antigen detection capability deteriorates due to masking and chemical modification

Engineering Contradiction:
Improvetissue preservationVSAvoidantigen detection capability
Core Design Contradiction:
Stability of the object's compositionVSMeasurement precision

Solution Approach 1:

The patent converts the harmful effect of aldehyde cross-linking (antigen masking) into a beneficial process by using aldehyde scavenging agents to reverse the cross-linking. The same aldehyde groups that caused antigen masking are now targeted for removal through reversible equilibrium reactions, transforming the fixation byproduct into a removable intermediate that can be eliminated to restore antigen detection capability.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

Aldehyde scavenging agents serve as intermediary substances that mediate between the fixed tissue and the detection system. These agents temporarily bind to aldehyde groups in reversible equilibrium, forming intermediate adducts that can be removed under controlled conditions, thereby facilitating antigen unmasking without directly altering the tissue structure.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Stability of the object's composition

If prolonged formaldehyde fixation is applied, then tissue preservation is improved, but antigen retrieval becomes more difficult due to irreversible cross-linking

Engineering Contradiction:
Improvetissue preservationVSAvoidantigen retrieval ease
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The patent employs parameter changes in pH and temperature to control the reversible equilibrium between aldehyde groups and aldehyde scavenging agents. By adjusting these parameters, the system can shift equilibrium toward adduct formation for removal, enabling antigen retrieval from prolongedy fixed tissues without compromising the fundamental tissue preservation achieved by formaldehyde fixation.

Inventive Principle:
Principle #35Parameter changes

3Shape

If aldehyde cross-linking is used to preserve tissue morphology, then tissue structure is maintained, but protein accessibility deteriorates due to dense cross-link networks

Engineering Contradiction:
Improvetissue morphologyVSAvoidprotein accessibility
Core Design Contradiction:
ShapeVSEase of operation

Solution Approach 1:

The dense cross-link network that initially appears harmful to protein accessibility is converted into a beneficial feature by exploiting the reversibility of aldehyde cross-linking. The aldehyde scavenging agents penetrate the cross-link network and convert stable cross-links into removable adducts, allowing protein accessibility to be restored while maintaining the overall tissue morphology preserved by the cross-linking.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively retrieves and detects proteins in tissues fixed with aldehyde-based agents, enhancing antigen detection and reducing autofluorescence, allowing for improved immunohistochemical analysis and preservation of tissue morphology.

Implementation Method 1

a reaction of the aldehyde scavenging agent with the aldehydes comprising the cross-linking agent retrieves the antigens

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

aldehyde and aldehyde adducts exist in a state of reversible equilibrium in the fixed compositions or tissues

Methodology Applied
Scientific EffectReversible equilibrium: Metastability

Implementation Method 3

heating the solution to about 60° C. to about 125° C. to reach a reversible equilibrium between aldehyde and aldehyde adducts

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 4

aldehyde scavenging agents in the presence of heating and at optimal pH can shift the equilibrium toward releasing aldehyde

Methodology Applied
Scientific EffectReversible equilibrium shift: Metastability

Implementation Method 5

optional nonionic surfactants to enhance fluorescence and reduce autofluorescence

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Data Source

PatentUS9506928B2Methods for retrieving antigens using aldehyde scavenging agents
Publication Date: 2016.11.29 UNIV HOUSTON SYST
  • US9506928B2 patent drawing
  • US9506928B2 patent drawing
  • US9506928B2 patent drawing

AI summary

Provided herein are methods, compounds, mixtures and formulations of antigen retrieval agent useful in retrieving antigens and improving the detection of amino acids, peptides and proteins or epitopes thereon in a tissue fixed with aldehyde-based cross-linking agents. Contacting the fixed tissue with a solution of the aldehyde scavenging agent causes reactivity with the aldehyde moieties to retrieve antigens and improve detection of the amino acids, peptides and proteins or epitopes. Also provided are kits comprising the antigen retrieval agent and, optionally, components for staining or detecting the proteins or the antigens or epitopes and instructions for using the kit. Further provided is a method for identifying an antigen retrieval agent. A fixed protein is contacted with an agent to be tested and heated in solution therewith. Detection of protein peaks via mass spectrometry indicates the tested agent is an antigen retrieval agent.